Shareholders' equity · 2011–2025
Arrowhead Pharmaceuticals shareholders' equity
$568M+980.9% · FY2025
Arrowhead Pharmaceuticals (ARWR) reported $568M in shareholders' equity for fiscal 2025, +980.9% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $568M | +980.9% | Open → |
| FY20242024-12-31 | $52.6M | −67.2% | Open → |
| FY20232023-12-31 | $160M | −57.5% | Open → |
| FY20222022-12-31 | $377M | +1.2% | Open → |
| FY20212021-12-31 | $373M | −18.0% | Open → |
| FY20202020-12-31 | $454M | −9.1% | Open → |
| FY20192019-12-31 | $500M | +190.7% | Open → |
| FY20182018-12-31 | $172M | +143.2% | Open → |
| FY20172017-12-31 | $70.8M | −27.6% | Open → |
| FY20162016-12-31 | $97.8M | +5.2% | Open → |
| FY20152015-12-31 | $92.9M | −36.5% | Open → |
| FY20142014-12-31 | $146M | +76.8% | Open → |
| FY20132013-12-31 | $82.7M | +821.8% | Open → |
| FY20122012-12-31 | $9.0M | −44.5% | Open → |
| FY20112011-12-31 | $16.2M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +29.0%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arrowhead Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/arrowhead-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arrowhead Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/arrowhead-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-arrowhead-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Arrowhead Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arrowhead-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000879407-26-000034 · February 5, 2026
{{cite web |title=Arrowhead Pharmaceuticals shareholders' equity — 10-Q (0000879407-26-000034) |url=https://www.sec.gov/Archives/edgar/data/879407/000087940726000034/arwr-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.